Patient 1 was “lost to follow up”, which means he has not turned up for his follow up scans. so he is not included in the calculation of disease control rate.
Apparently Patient 1, who was a 20 something male with stage 4 cancer, was still alive but refused to participate in the study any further. This is not an uncommon event.
CHM Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)